Sort   by:  
 Page size 
UnknownQuality of life in pediatric patients on a paracorporeal ventricular assist device with a novel mobile driving system.
Not available
S-EPMC11935330 | biostudies-literature
UnknownDevelopment of a Hospital Compounded, Taste-Masked, Temozolomide Oral Suspension and 5-Year Real-Life Experience in Treating Paediatric Patients.
Not available
S-EPMC9146721 | biostudies-literature
UnknownAmino Acid Variation in HLA Class II Proteins Is a Major Determinant of Humoral Response to Common Viruses.
Not available
S-EPMC4667104 | biostudies-literature
UnknownHIV-1 clade promoters strongly influence spatial and temporal dynamics of viral replication in vivo.
Not available
S-EPMC546425 | biostudies-literature
UnknownPrevention of tau seeding and propagation by immunotherapy with a central tau epitope antibody.
Not available
S-EPMC6536853 | biostudies-literature
TranscriptomicsTranscription profiling of mouse CD8 T cells in response to P1A antigen expressing tumor cells or cells not expressing 1A antigen
Activation status of CD8 T cells in response to a tumor challenge. Although both natural killer (NK) cells and CD8 T cells are capable of anti-tumor responses, Recombinase Activating Gene (RAG)-deficient mice, which have a normal component of NK cells, are incapable of rejecting the P815 mastocytoma...
ORGANISM(S): Mus musculus 
2007-12-01 | E-MEXP-1285 | biostudies-arrayexpress
TranscriptomicsTranscription profiling of mouse NK cells in presence/absence of activated CD8 T cells
we compare NK cells in presence of activated CD8 T cells or not. Although both natural killer (NK) cells and CD8 T cells are capable of anti-tumor responses, Recombinase Activating Gene (RAG)-deficient mice, which have a normal component of NK cells, are incapable of rejecting the P815 mastocytoma t...
ORGANISM(S): Mus musculus 
2007-11-01 | E-MEXP-1284 | biostudies-arrayexpress
UnknownDeep learning can predict survival directly from histology in clear cell renal cell carcinoma.
Not available
S-EPMC9385058 | biostudies-literature
UnknownEASIX-guided risk stratification for complications and outcome after CAR T-cell therapy with ide-cel in relapsed/refractory multiple myeloma.
Not available
S-EPMC11459298 | biostudies-literature
UnknownBridging intensity is associated with impaired hematopoietic recovery after BCMA CAR-T therapy for multiple myeloma.
Not available
S-EPMC12361772 | biostudies-literature
Sort   by:  
 Page size